PMID: 792627Nov 1, 1976Paper

Infective endocarditis and access site infections in patients on hemodialysis

Medicine
A S Cross, R T Steigbigel

Abstract

Infective endocarditis has been a subtle and very often lethal complication of hemodialysis. Thirty-five episodes have been described to date. Antecedent infections, particularly those involving the access site, access manipulation, and dental work appear to predispose to IE. Once IE is acquired, factors associated with mortality are involvement of two or more valves, infection caused by enterococci, antecedent infection, steroid therapy, infection in the first year post-access insertion and patient age over 46. The incidence of access infection with the arteriovenous fistula is significantly less than that associated with the arteriovenous cannula. Staphylococci are the most common organisms in access infections and in IE. Gram-negative bacilli and particularly Pseudomonas aeruginosa are a frequent cause of access infection but an unusual cause of IE. Access removal may be madatory in the successful management of IE in patients on hemodialysis.

Citations

Sep 1, 1988·The Japanese Journal of Surgery·K KinoshitaK Tokunaga
Sep 1, 1983·The British Journal of Oral Surgery·J CampbellT W MacFarlane
Sep 26, 2001·Infectious Disease Clinics of North America·S Vas, D G Oreopoulos
Jul 9, 2003·Kidney International·Timothy DoultonDavid J A Goldsmith
May 20, 2003·Seminars in Dialysis·Stephen SandroniDeborah Brouwer
Jun 22, 2000·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·C W Werner, T F Saad
Nov 1, 1995·Journal of Biomechanical Engineering·J F Wilson, J S Davis
Nov 1, 1979·Antimicrobial Agents and Chemotherapy·T W Lane, E Abrutyn
Aug 1, 1993·Postgraduate Medical Journal·D P Naidoo
Apr 22, 1999·Postgraduate Medical Journal·J T WalshP M Schofield
May 29, 2004·The American Journal of the Medical Sciences·Suraj MarajMorris N Kotler
Apr 16, 2003·The American Journal of the Medical Sciences·Farrin A Manian
Sep 1, 1982·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S E GoldblumW P Reed
Mar 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S E GoldblumP S Avasthi
Dec 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L D QuarlesS G Rostand
Oct 21, 2000·Mayo Clinic Proceedings·J T McCarthy, J M Steckelberg
May 29, 2007·The Annals of Thoracic Surgery·Desikan KamalakannanLouis D Saravolatz
Feb 1, 1987·The British Journal of Oral & Maxillofacial Surgery·C J SmythS J Ballagh
Jul 1, 1979·Oral Surgery, Oral Medicine, and Oral Pathology·M H Chow, D S Peterson
Jul 13, 2001·Infectious Disease Clinics of North America·V R Minnaganti, B A Cunha
Aug 1, 1996·Cardiology Clinics·J S Child
Aug 1, 1996·Cardiology Clinics·B M KubakC D Holt
Aug 24, 1996·Lancet·C Deighan, M Boulton-Jones
Aug 1, 1986·The Annals of Thoracic Surgery·K H LawsH W Bender
Jan 1, 1977·Journal of Dialysis·D L LatosR H Alford
Oct 1, 1979·The American Journal of Medicine·L J WheatA White
Jun 1, 1979·Disease-a-month : DM·A S Bayer, L B Guze
May 24, 2007·The International Journal of Artificial Organs·R Pandey, R Sam
Apr 3, 2021·Journal of the American College of Cardiology·Juan M PericàsICE Investigators

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.